A61K 31/06
The aromatic ring being substituted by nitro groups
Official title: the aromatic ring being substituted by nitro groups
A61K31/06 (The aromatic ring being substituted by nitro groups) appears on 68 US grants and 118 published applications in this corpus.
Search patents in A61K- Granted patents
- 68
- Published applications
- 118
- Assignees
- 81
- Inventors
- 217
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 4 |
| 2003 | 2 | 4 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 3 |
| 2007 | 0 | 3 |
| 2008 | 0 | 0 |
| 2009 | 1 | 6 |
| 2010 | 1 | 7 |
| 2011 | 0 | 3 |
| 2012 | 1 | 3 |
| 2013 | 3 | 5 |
| 2014 | 3 | 5 |
| 2015 | 1 | 4 |
| 2016 | 2 | 7 |
| 2017 | 3 | 6 |
| 2018 | 5 | 9 |
| 2019 | 3 | 5 |
| 2020 | 7 | 12 |
| 2021 | 4 | 4 |
| 2022 | 3 | 6 |
| 2023 | 5 | 8 |
| 2024 | 2 | 3 |
| 2025 | 1 | 5 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment of infections9 Jun 2026US 12,648,997 B2Ascendis Pharma A/S
- Antimicrobial adjuvant containing biphenyl derivative compound as active ingredient, and uses thereof14 Apr 2026US 12,599,575 B2Korea Research Institute of Bioscience and Biotechnology
- Cosmetic compositions and methods of use15 Apr 2025US 12,274,773 B2K&K Biotech
- Sensitization of cancer cells to differentiation therapy with mitochondrial uncoupler niclosamide ethanolamine5 Mar 2024US 11,918,550 B2The Board of Trustees of the Leland Stanford Junior University
- 2,4-dinitrophenol formulations and methods using same30 Jan 2024US 11,883,369 B2Yale University
- Composition for improving skin comprising carnitinesalicylate as an active ingredient23 Jul 2026US 2026/0207629 A1LG H&H Co., Ltd.
- 2,4 DNP and Prodrugs Thereof for Treatment of Cancer23 Apr 2026US 2026/0108476 A1Mitochon Pharmaceuticals, Inc.
- Methods for suppressing accumulation of reflux-induced protein adducts26 Mar 2026US 2026/0083686 A1The United States Government as represented by the Department of Veterans Affairs
- Synergistic Stimulation of Mucociliary Clearance to Treat Mucus Obstruction in Cystic Fibrosis and Other Muco-Obstructive Disorders26 Mar 2026US 2026/0083698 A1The Board of Trustees of the Leland Stanford Junior University
- Combination treatments for depression utilizing an nmdar antagonist2 Oct 2025US 2025/0302825 A1Glytech, Inc.
Most cited
By later US patents
- Chemical induced intracellular hyperthermia40US 7,635,722 B1Saint Jude Pharmaceuticals, Inc. · 2009
- Cancer therapy system for effecting oncolysis of malignant neoplasms39US 4,935,450 ATherapeutical Systems Corp. · 1990
- Composition and method for treatment of depression and psychosis in humans26US 9,486,453 B2Glytech, Inc. · 2016
- Method for producing oncolysis23US 4,724,234 ATherapeutical Systems Corp. · 1988
- Method for increasing tumor sensitivity to chemotherapy23US 5,005,588 A1991